絞り込み

17881

広告

Tau protein and neurodegeneration.

著者 Goedert M
Semin Cell Dev Biol.2004 Feb ; 15(1):45-9.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK. mg@mrc-lmb.cam.ac.uk

スターを付ける スターを付ける     (76view , 0users)

Full Text Sources

Medical

MAPT gene

Miscellaneous

Other Literature Sources

Tau protein is the major component of the intracellular filamentous deposits that define a number of neurodegenerative diseases. They include the largely sporadic Alzheimer's disease, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Pick's disease (PiD), argyrophilic grain disease, as well as the inherited frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The identification of mutations in Tau as the cause of FTDP-17 established that dysfunction or misregulation of tau protein is sufficient to cause neurodegeneration and dementia. At an experimental level, the new understanding is leading to the development of good transgenic animal models of the tauopathies.
PMID: 15036206 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード